Eli Lilly Bolsters Metabolic Portfolio with Evotec and Abbisko Collaborations
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)
Published: 27 Jan-2022
DOI: 10.3833/pdr.v2022.i1.2665 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Eli Lilly has entered two key collaboration deals on the same day in a bid to expand its metabolic portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS